DRREDDYPharmaceuticals
Dr Reddys Laboratories Ltd — PE Ratio & Valuation Analysis
₹1254.90
-1.46%
Current P/E18.23xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E22.7x19.8% below avg
✅
42.6% Discount to Industry
DRREDDY P/E 18.23x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹67.78 | ₹1271 | 18.8x |
| 2024 | ₹66.80 | ₹1389 | 20.8x |
| 2023 | ₹54.18 | ₹1160 | 21.4x |
| 2022 | ₹28.34 | ₹848 | 29.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Dr Reddys Laboratories Ltd Valuation
Dr Reddys Laboratories Ltd (DRREDDY) currently trades at 18.23x earnings. The Pharmaceuticals sector average PE is 31.77x. DRREDDY is trading at a discount to peers — may indicate relative value. Historically, DRREDDY has traded at an average PE of 22.7x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
17.96%
Dividend Yield
0.63%
More on Dr Reddys Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.